Conference Coverage

Research refining radiomic features for lung cancer screening


 

AT AN AACR/IASLC JOINT CONFERENCE

References

“In the future, we envision that all medical images will be converted to mineable data with the process of radiomics as part of standard of care,” Dr. Gillies said in an interview. “Such data have already shown promise to increase the precision and accuracy of diagnostic images, and hence, will increasingly be used in therapy decision support.”

Among the many challenges that first need to be resolved are that images are often captured with settings and filters that can be different even within a single institution. The inconsistency adds noise to the data that are extracted by computers.

“Hence, the most robust data we have today are generated by radiologists themselves, although this has its own challenges of being time-consuming with inter-reader variability,” Dr. Gillies noted.

Another major challenge is sharing of the image data. Right now, radiomics is practiced at only a few research hospitals and thus, building large cohort studies requires that the images be moved across site. In the future, the researchers anticipate that software can be deployed across sites to enable radiomic feature extraction, which would mean that only the extracted data will have to be shared, he said.

pwendling@frontlinemedcom.com

Pages

Recommended Reading

Alectinib FDA approved to treat metastatic ALK-positive NSCLC*
MDedge Hematology and Oncology
Oncology 2015: new therapies and new transitions toward value-based cancer care
MDedge Hematology and Oncology
Cancer clinical trial enrollment of diverse and underserved patients within an urban safety net hospital
MDedge Hematology and Oncology
Mutation in ALK-rearranged lung cancer confers resistance to lorlatinib, restores sensitivity to crizotinib
MDedge Hematology and Oncology
Former smokers turning to e-cigarettes
MDedge Hematology and Oncology
Late risks of breast cancer RT are higher for smokers
MDedge Hematology and Oncology
Families perceive few benefits from aggressive end-of-life care
MDedge Hematology and Oncology
Adjuvant therapy extends survival in early SCLC
MDedge Hematology and Oncology
Deciphering lung cancer biomarkers shrouded in tobacco smoke
MDedge Hematology and Oncology
Presurgery radiation shows benefit in lung cancer
MDedge Hematology and Oncology